Lotus Eye Hospital & Institute Ltd (LOTUSEYE) is currently trading at 105.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Lotus Eye Hospital & Institute Limited operates a network of nine specialty ophthalmology centers across Tamil Nadu and Kerala, providing super‑specialty eye care services including cataract, LASIK and corneal procedures; the group reported its unaudited financial results for the quarter and half year ended September 30, 2025, with board approval on November 12, 2025. Revenue from operations for Q2 ended September 30, 2025 was Rs. 1,303.84 lakhs, largely stable year‑on‑year and slightly down quarter‑on‑quarter; half‑year revenue stood at Rs. 2,655.53 lakhs, a small improvement versus the prior half, indicating modest organic volume growth from existing centers. Profitability is thin but positive: the company reported a small quarterly PAT (single‑digit lakhs) and a half‑year PAT of Rs. 61.73 lakhs, with the prior fiscal year PAT of Rs. 59.11 lakhs, showing limited but consistent net earnings despite a large asset base and operating expenses. Balance sheet shows total assets of Rs. 7,151.48 lakhs as at Sept 30, 2025 with equity of Rs. 2,079.63 lakhs and modest capital work in progress, indicating a largely asset‑intensive model with limited recent capex; cash flow from operations was positive in the period but investing and financing activities show net outflows. Clinically, Lotus positions itself as a technology adopter and first‑mover in the region, with historical launches of advanced LASIK and laser cataract technologies and a consolidated footprint that includes nine operation theatres and approximately 120 beds (excluding eye‑camp capacity).

Over the past 52 weeks, Lotus Eye Hospital & Institute Ltd has traded between a low of ₹97.60 and a high of ₹153.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Lotus Eye Hospital & Institute Ltd has a market capitalization of approximately 222.83. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Lotus Eye Hospital & Institute Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 1485.53 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 222.83 Cr, Lotus Eye Hospital & Institute Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Lotus Eye Hospital & Institute Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Lotus Eye Hospital & Institute Ltd is 1485.53. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.